The burden of healthcare costs associated with prostate cancer in Ireland
Burns RM., Leal J., Wolstenholme J., O’Neill C., Sullivan FJ., Drummond FJ., Sharp L.
http://www.grhta.com/article/d2c3cb15-cc4b-43af-b15b-aba4baf7821d
Richéal M Burns
MSc PhD
Senior Researcher
Richéal was appointed senior researcher in October 2014 after previously holding a joint position at the Health Economics Research Centre (HERC) and the Surgical Intervention Trials Unit (SITU), where Richéal undertook health economic evaluations alongside a range of surgical trials including the UK TAVI trial.
In her current role, Richéal continues to provide health economic support alongside a range of RCTs as well as involvement in burden of illness studies. Having a keen interest in mental health, PROMs and inequality in health outcomes, Richéal will also follow on from previous work in the research areas of Prostate Cancer, Inflammatory Bowel Disease and general well-being.
Previous to this, Richéal was based at NUI Galway, undertaking a MSc in Health Economics in 2009-2010 and following on to commence a PhD in 2011 funded by the Health Research Board; the research project afforded the opportunity to regularly visit HERC from October 2012 working on the modelling aspects of her PhD with Dr. Jane Wolstenholme and Dr. José Leal.
While at NUI Galway, Richéal also secured several internal grants to undertake various projects relating to quality of life and mental health concerns of the student population as well as teaching microeconomics, econometrics and quantitative research methods at both the undergraduate and postgraduate level for three years.
Recent publications
-
Including health economic analysis in pilot studies: lessons learned from a cost-utility analysis within the PROSPECTIV pilot study
Journal article
Burns RM. et al, (2017), Global and Regional Health Technology Assessment
-
Should the Republic of Ireland introduce a national prostate-specific antigen testing programme for the secondary detection of prostate cancer? Results from a population-based cost-effectiveness analysis
Conference paper
Burns RM. et al, (2017), In: European Journal of Cancer February 2017Volume 72, Supplement 1, Page S117
-
Machine perfusion in liver transplantation: practical issues to consider in the design and conduct of a complex multinational interventional trial and the potential impact on the analysis
Conference paper
Chiocchia V. et al, (2017), Trials, 18, 200 - 200
-
Evidence-gathering across industry and academia on early health technology assessment (HTA) of medical devices: Survey design and piloting
Conference paper
Manetti S. et al, (2017), IFMBE Proceedings, 65, 631 - 634
-
The burden of healthcare costs associated with prostate cancer in Ireland
Journal article
Burns RM. et al, (2016), Global and Regional Health Technology Assessment, 4, 0 - 0
-
Economic burden of malignant blood disorders across Europe: a population-based cost analysis.
Journal article
Burns R. et al, (2016), Lancet Haematol, 3, e362 - e370
-
Economic burden of non-malignant blood disorders across Europe: a population-based cost study.
Journal article
Luengo-Fernandez R. et al, (2016), Lancet Haematol, 3, e371 - e378
-
Adopting an Evidence Synthesis Approach for Assessing Cost-Effectiveness of Screening Strategies for Prostate Cancer in Ireland.
Conference paper
Burns RM. et al, (2014), Value Health, 17, A552 - A553